CHICAGO, IL — AIDS Foundation Chicago (AFC) celebrates Friday’s passage of the Inflation Reduction Act of 2022 in the U.S. House of Representatives. The bill cleared the Senate last week and is headed to President Biden for his signature. AFC cheers the provisions that will allow the federal government to negotiate drug prices and reign in the pharmaceutical industry, which has for decades indiscriminately raised the price of drugs that people living with HIV and millions of Americans rely on to stay healthy. The bill also includes robust funding for combating climate change, changes to the tax code to make it more equitable, and the most consequential changes to health care policy since the passage of the Affordable Care Act.
On the health care front, this bill tackles the high cost of prescription drugs and makes health care more affordable for Americans, particularly Medicare recipients. Medicare is the federal health insurance program for people 65 and older and younger adults with permanent disabilities—including people living with HIV. Medicare alone accounts for over 50% of all federal funding dedicated to HIV care and services. Specifically, the bill:
This is a huge win for Americans as it lowers the cost of health care and paves the way for the government to negotiate lower prices on more medications. It is not yet clear whether HIV medications will make the list of high-cost drugs subject to negotiation. However, it is estimated that the drug price negotiations will save the federal government $288 billion over a decade, which is taxpayer money that can be reinvested into other priorities that affect people living with HIV. AIDS Foundation Chicago will continue to support any measure that makes health care accessible and affordable for more people.
The bill imposes a new 15% corporate minimum tax on the profits companies report to shareholders. AFC strongly supports provisions that will raise new revenue, and which hold large corporations accountable in paying their fair share of taxes.